Author:
Staerk Laila,Fosbøl Emil Loldrup,Gadsbøll Kasper,Sindet-Pedersen Caroline,Pallisgaard Jannik Langtved,Lamberts Morten,Lip Gregory Y. H.,Torp-Pedersen Christian,Gislason Gunnar Hilmar,Olesen Jonas Bjerring
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Camm, A. J. et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation An update of the 2010 ESC Guidelines for the management of atrial fibrillationDeveloped with the special contribution of the European Heart Rhythm Association. Europace 14, 1385–1413 (2012).
2. Lip, G. Y. H. & Lane, D. A. Stroke prevention in atrial fibrillation: A systematic review. JAMA 313, 1950–1962 (2015).
3. Olesen, J. B. et al. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011–2013. EP Eur. 17, 187–193 (2015).
4. Halvorsen, S. et al. Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial. Eur. Heart J. 35, 1864–1872 (2014).
5. Connolly, S. J. et al. Dabigatran versus Warfarin in Patients with Atrial Fibrillation. N. Engl. J. Med. 361, 1139–1151 (2009).
Cited by
80 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献